ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:09
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 346


Drug details and screening numbers

Drug Name: THZ-2-102-1
Drug ID: 346
Synonyms:
Brand name:
Target: CDK7

Number of cell lines screened: 905
Screening concentration range(s): 0.009765625 to 2.5 uM and 0.078125 to 20 uM


Statistically significant associations identified = 3
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a162
EWSR1-FLI1_mut
346
1
1
THZ-2-102-1
CDK7
17
886
0.916, 2.996
-1.5
-3.97
-2.47
0.98 .
0.98 .
1.1 *
5.13e-05
7.22e-38
3.51e-01
5.2
a232
MLL2_mut
346
1
1
THZ-2-102-1
CDK7
94
809
0.916, 2.996
-1.42
-2.68
-1.26
0.51 .
0.5
0.61 .
1.25e-04
8.7e-38
3.52e-01
8.8
a254
gain_cnaPANCAN349_(INPP4A)
346
1
1
THZ-2-102-1
CDK7
23
880
0.916, 2.996
-1.6
0.479
2.08
0.83 .
0.83 .
0.72 .
1.58e-04
9.14e-38
3.52e-01
10


All-tests volcano plot